ARCHIVES

NCIs FY95 Bypass To Justify $3.47 Billion, includes $490 million For Breast Cancer Research

This article is from The Cancer Letter archive.

Vol. 19 No. 20 | May 14, 1993

Download PDF Visit The Full Archive

Related Articles

FDA Begins To Examine Its Role In Allowing Misleading Consumer Advertising.

May 18, 2007

Amgen’s Aranesp Sales Dropped By Half, Continue To Fall.

November 14, 2008

National Comprehensive Center Network, Quintiles Oncology, To Collaborate On Trials

March 5, 1999

In Brief: NCAB Lacked Courage On Some Special Actions, Amos Says; Pick Reviewers On Ability Only, Scientist Asks

July 30, 1982

NCI Advisors Approve Plans To Continue Current Research Programs.

July 3, 2008

AACR, ASCO Publish Reports Examining U.S. Cancer Care

April 4, 2014